cbdMD (YCBD) Non-Current Deferred Tax Liability (2016 - 2021)
cbdMD (YCBD) reported Non-Current Deferred Tax Liability of $6.1 million for Q3 2021, up 583.35% on a YoY basis from $895000.0 in Q3 2020, and up 4604.62% sequentially from $130000.0 in Q2 2021.
cbdMD (YCBD) Non-Current Deferred Tax Liability (2016 - 2021) Analysis & Trends
cbdMD (YCBD) has 6 years of Non-Current Deferred Tax Liability data on file, last reported at $6.1 million in Q3 2021.
- For the quarter ending Q3 2021, Non-Current Deferred Tax Liability rose 583.35% year-over-year to $6.1 million; the trailing twelve-month figure through Sep 2021 stood at $6.1 million (up 583.35% YoY), and the FY2021 full-year result was $6.1 million, up 583.35% from the prior year.
- Non-Current Deferred Tax Liability rose to $6.1 million in Q3 2021, from $130000.0 in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $6.1 million in Q3 2021 to a low of $15000.0 in Q4 2017.
- A 5-year average of $1.7 million and a median of $563000.0 in 2020 frame the typical range for Non-Current Deferred Tax Liability.
- Across the five-year window, Non-Current Deferred Tax Liability surged 33206.67% in 2018 and sank 60.05% in 2020, its largest moves.
- Tracing YCBD's Non-Current Deferred Tax Liability over 5 years: stood at $15000.0 in 2017, then surged by 33206.67% to $5.0 million in 2018, then plunged by 55.16% to $2.2 million in 2019, then sank by 74.87% to $563000.0 in 2020, then soared by 986.32% to $6.1 million in 2021.
- Business Quant data shows YCBD's Non-Current Deferred Tax Liability at $6.1 million in Q3 2021, $130000.0 in Q2 2021, and $27000.0 in Q1 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | cbdMD | 438,678.80 | -2.95 Mn | 3.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 6.12 Mn |
| Sep 30, 2021 | 6.12 Mn |
| Jun 30, 2021 | 130,000.00 |
| Jun 30, 2021 | 130,000.00 |
| Mar 31, 2021 | 27,000.00 |
| Mar 31, 2021 | 27,000.00 |
| Dec 31, 2020 | 563,000.00 |
| Dec 31, 2020 | 563,000.00 |
| Sep 30, 2020 | 895,000.00 |
| Sep 30, 2020 | 895,000.00 |
| Sep 30, 2019 | 2.24 Mn |
| Sep 30, 2019 | 2.24 Mn |
| Jun 30, 2019 | 2.83 Mn |
| Jun 30, 2019 | 2.83 Mn |
| Mar 31, 2019 | 3.92 Mn |
| Mar 31, 2019 | 3.92 Mn |
| Dec 31, 2018 | 5.00 Mn |
| Dec 31, 2018 | 5.00 Mn |
| Sep 30, 2018 | 21,000.00 |
| Sep 30, 2018 | 21,000.00 |